Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma

Eur J Cancer. 2018 Apr:93:147-149. doi: 10.1016/j.ejca.2018.01.062. Epub 2018 Feb 12.

¹ Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. Electronic address: [email protected].
² Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
³ Department of Dermatology, Bordeaux, France.
⁴ Department of Dermatology, Le Mans, France.
⁵ Centre de Recherche en Cancérologie de Lyon, Institut de Cancérologie des Hospices Civils de Lyon, Université de Lyon, Lyon, France.
⁶ Department of Dermatology, Université Paul Sabatier, Institut Universitaire du Cancer de Toulouse-Oncopole et CHU Larrey, Toulouse, France.
⁷ Biostatistics, AP-HP, Hôtel-Dieu Hospital, Paris, France.
⁸ Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
⁹ APHP Dermatology, Department of Dermatology and CIC, Paris 7 Diderot University, INSERM U976, Hôpital Saint-Louis, Paris, France.

No abstract available

Publication types